Patents by Inventor H. Anne Pereira

H. Anne Pereira has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7745401
    Abstract: A method of treating fungal infections by treatment with CAP37 peptides and derivatives thereof, including peptide analogs having serine or threonine substitutions at least one of the two cysteine residues therein. Other substitutions of the amino acid residues of the peptide are also contemplated.
    Type: Grant
    Filed: July 31, 2006
    Date of Patent: June 29, 2010
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: H. Anne Pereira, Paul Fidel
  • Publication number: 20100136574
    Abstract: The present invention in one embodiment is an early detection marker for chronic or acute inflammatory-associated diseases. Chronic diseases may include atherosclerosis, Alzheimer's disease, asthma, rheumatoid arthritis, osteoarthritis, and inflammatory diseases of the bowel such as Crohn's disease, Ulcerative colitis, Irritable bowel syndrome and Inflammatory bowel disease. Acute diseases may include sepsis, acute systemic infections, acute lung injury, and acute respiratory distress syndrome.
    Type: Application
    Filed: February 1, 2010
    Publication date: June 3, 2010
    Inventor: H. Anne Pereira
  • Patent number: 7655480
    Abstract: The present invention in one embodiment is an early detection marker for chronic or acute inflammatory-associated diseases. Chronic diseases may include atherosclerosis, Alzheimer's disease, asthma, rheumatoid arthritis, osteoarthritis, and inflammatory diseases of the bowel such as Crohn's disease, Ulcerative colitis, Irritable bowel syndrome and Inflammatory bowel disease. Acute diseases may include sepsis, acute systemic infections, acute lung injury, and acute respiratory distress syndrome.
    Type: Grant
    Filed: February 28, 2007
    Date of Patent: February 2, 2010
    Assignee: The Board of Regents of the University of Oklahoma
    Inventor: H. Anne Pereira
  • Patent number: 6730659
    Abstract: Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: May 4, 2004
    Assignee: The Board of Regents of the University of Oklahoma
    Inventor: H. Anne Pereira
  • Publication number: 20040048792
    Abstract: Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated.
    Type: Application
    Filed: December 20, 2002
    Publication date: March 11, 2004
    Inventor: H. Anne Pereira
  • Patent number: 6514701
    Abstract: Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated.
    Type: Grant
    Filed: July 19, 2000
    Date of Patent: February 4, 2003
    Assignee: The Board of Regents of the University of Oklahoma
    Inventor: H. Anne Pereira
  • Patent number: 6107460
    Abstract: Novel peptide analogs derived from the native sequences of CAP37 peptides 20-44 and 23-42, and their use as therapeutics against bacterial infections and diseases caused by bacterial infection. The peptide analog includes a serine or threonine substitution at one of the two cysteine residues at positions 26 and 42. Substitutions of the native peptide are also contemplated.
    Type: Grant
    Filed: March 1, 1999
    Date of Patent: August 22, 2000
    Assignee: The Board of Regents of the University of Oklahoma
    Inventor: H. Anne Pereira